186 related articles for article (PubMed ID: 28389407)
1. D-penicillamine combined with inhibitors of hydroperoxide metabolism enhances lung and breast cancer cell responses to radiation and carboplatin via H
Sciegienka SJ; Solst SR; Falls KC; Schoenfeld JD; Klinger AR; Ross NL; Rodman SN; Spitz DR; Fath MA
Free Radic Biol Med; 2017 Jul; 108():354-361. PubMed ID: 28389407
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of carboplatin-mediated lung cancer cell killing by simultaneous disruption of glutathione and thioredoxin metabolism.
Fath MA; Ahmad IM; Smith CJ; Spence J; Spitz DR
Clin Cancer Res; 2011 Oct; 17(19):6206-17. PubMed ID: 21844013
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism.
Rodman SN; Spence JM; Ronnfeldt TJ; Zhu Y; Solst SR; O'Neill RA; Allen BG; Guan X; Spitz DR; Fath MA
Radiat Res; 2016 Oct; 186(4):385-395. PubMed ID: 27643875
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel combined with inhibitors of glucose and hydroperoxide metabolism enhances breast cancer cell killing via H2O2-mediated oxidative stress.
Hadzic T; Aykin-Burns N; Zhu Y; Coleman MC; Leick K; Jacobson GM; Spitz DR
Free Radic Biol Med; 2010 Apr; 48(8):1024-33. PubMed ID: 20083194
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous inhibition of glutathione- and thioredoxin-dependent metabolism is necessary to potentiate 17AAG-induced cancer cell killing via oxidative stress.
Scarbrough PM; Mapuskar KA; Mattson DM; Gius D; Watson WH; Spitz DR
Free Radic Biol Med; 2012 Jan; 52(2):436-43. PubMed ID: 22100505
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of human head and neck cancer cells to combined inhibition of glutathione and thioredoxin metabolism.
Sobhakumari A; Love-Homan L; Fletcher EV; Martin SM; Parsons AD; Spitz DR; Knudson CM; Simons AL
PLoS One; 2012; 7(10):e48175. PubMed ID: 23118946
[TBL] [Abstract][Full Text] [Related]
7. Combined inhibition of glycolysis, the pentose cycle, and thioredoxin metabolism selectively increases cytotoxicity and oxidative stress in human breast and prostate cancer.
Li L; Fath MA; Scarbrough PM; Watson WH; Spitz DR
Redox Biol; 2015; 4():127-35. PubMed ID: 25560241
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glutamate cysteine ligase activity sensitizes human breast cancer cells to the toxicity of 2-deoxy-D-glucose.
Andringa KK; Coleman MC; Aykin-Burns N; Hitchler MJ; Walsh SA; Domann FE; Spitz DR
Cancer Res; 2006 Feb; 66(3):1605-10. PubMed ID: 16452219
[TBL] [Abstract][Full Text] [Related]
9. Copper chelation by D-penicillamine generates reactive oxygen species that are cytotoxic to human leukemia and breast cancer cells.
Gupte A; Mumper RJ
Free Radic Biol Med; 2007 Nov; 43(9):1271-8. PubMed ID: 17893040
[TBL] [Abstract][Full Text] [Related]
10. Disulfiram causes selective hypoxic cancer cell toxicity and radio-chemo-sensitization via redox cycling of copper.
Falls-Hubert KC; Butler AL; Gui K; Anderson M; Li M; Stolwijk JM; Rodman SN; Solst SR; Tomanek-Chalkley A; Searby CC; Sheffield VC; Sandfort V; Schmidt H; McCormick ML; Wels BR; Allen BG; Buettner GR; Schultz MK; Spitz DR
Free Radic Biol Med; 2020 Apr; 150():1-11. PubMed ID: 32032663
[TBL] [Abstract][Full Text] [Related]
11. Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach.
Kiebala M; Skalska J; Casulo C; Brookes PS; Peterson DR; Hilchey SP; Dai Y; Grant S; Maggirwar SB; Bernstein SH
Exp Hematol; 2015 Feb; 43(2):89-99. PubMed ID: 25448488
[TBL] [Abstract][Full Text] [Related]
12. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ
Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584
[TBL] [Abstract][Full Text] [Related]
13. An investigation into copper catalyzed D-penicillamine oxidation and subsequent hydrogen peroxide generation.
Gupte A; Mumper RJ
J Inorg Biochem; 2007 Apr; 101(4):594-602. PubMed ID: 17275091
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of intracellular iron using iron sucrose enhances the toxicity of pharmacological ascorbate in colon cancer cells.
Brandt KE; Falls KC; Schoenfeld JD; Rodman SN; Gu Z; Zhan F; Cullen JJ; Wagner BA; Buettner GR; Allen BG; Berg DJ; Spitz DR; Fath MA
Redox Biol; 2018 Apr; 14():82-87. PubMed ID: 28886484
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes.
Lipsky PE
J Clin Invest; 1984 Jan; 73(1):53-65. PubMed ID: 6606652
[TBL] [Abstract][Full Text] [Related]
16. Anti-Cancer Effects of Auranofin in Human Lung Cancer Cells by Increasing Intracellular ROS Levels and Depleting GSH Levels.
Cui XY; Park SH; Park WH
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014444
[TBL] [Abstract][Full Text] [Related]
17. 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells.
Simons AL; Ahmad IM; Mattson DM; Dornfeld KJ; Spitz DR
Cancer Res; 2007 Apr; 67(7):3364-70. PubMed ID: 17409446
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor effect of L-buthionine sulfoximine or ionizing radiation by copper complexes with 2,2´-biquinoline and sulfonamides on A549 2D and 3D lung cancer cell models.
Cadavid Vargas JF; Villa Perez C; Soria DB; Guerci A; Di Virgilio AL
J Biol Inorg Chem; 2022 Apr; 27(3):329-343. PubMed ID: 35247094
[TBL] [Abstract][Full Text] [Related]
19. Peroxide toxicity in conditioned lens epithelial cells--evaluation of multi-defense systems.
Ma W; Kleiman NJ; Sun F; Li D; Spector A
Exp Eye Res; 2003 Dec; 77(6):711-20. PubMed ID: 14609559
[TBL] [Abstract][Full Text] [Related]
20. Disulfiram anti-cancer efficacy without copper overload is enhanced by extracellular H2O2 generation: antagonism by tetrathiomolybdate.
Calderon-Aparicio A; Strasberg-Rieber M; Rieber M
Oncotarget; 2015 Oct; 6(30):29771-81. PubMed ID: 26356671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
